Autoimmune Disease Series--

Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus (T1DM), also known as insulin-dependent diabetes mellitus, is a chronic autoimmune disease characterized by absolute insulin deficiency due to damage to pancreatic β-cells, which often develops in childhood and adolescence, but may affect people of all ages. Typical symptoms include polyuria, polydipsia, polyphagia, and weight loss, which may lead to acute complications such as ketoacidosis in severe cases.

The research for type 1 diabetes treatment covers a wide range of areas, including insulin therapy, automated insulin delivery systems (AIDs), insulin-assisted therapies, and GIP/GLP-1 receptor agonists. The current direction of its drug development covers a wide range of aspects ranging from immunomodulation, β-cell protection and regeneration to specific hormone receptor antagonism and activation, as described below:

  • Immunomodulation and inflammation suppression: Studies have shown that protecting pancreatic β-cells through immunomodulation or suppression of inflammation holds promise for delaying or stopping disease progression. For example, CTLA4-Ig (abatacept) , an immunomodulator, was used in patients with T1DM and was able to slow the decline in β-cell function and maintain the effect for at least one year after discontinuation of the drug [1]. In addition, abatacept shows potential as a promising experimental drug in T1DM through specific immunomodulation without causing systemic immunosuppression [2].
  • Glucagon receptor antagonism and activation: The role of glucagon in T1DM has received attention, and blocking glucagon receptors or inhibiting glucagon secretion by α-cells has become a new therapeutic direction. In addition, the glucagon-like peptide-1 (GLP-1) system has received attention as a therapeutic target because of its multimodal action and low hypoglycemic tendency [3].
  • Endoplasmic reticulum stress: endoplasmic reticulum stress is considered to be an important pathological feature in the pathogenesis of T1DM, and drugs targeting pathological endoplasmic reticulum stress are expected to restore pancreatic β-cells quantity and quality.
  • Autoantigens and cytokines: therapeutic strategies targeting autoantigens (e.g., GAD65, insulin, etc.) and cytokines in T1DM are also under investigation. These autoantigens are not only target proteins for humoral autoimmune responses, but may also be target molecules for autoreactive T lymphocytes.

Currently, targeted immunotherapy targeting T-lymphocytes, B-lymphocytes, and cytokines has made great progress. In addition, a variety of new drugs including SGLT inhibitors, GLP-1 agonists, immunomodulatory drugs (including autoantigens and anti-cytokines), and β-cell regenerative agents are in clinical development. Insulin gene therapy has also shown potential for treating T1DM as an alternative strategy to correct hyperglycemia by expressing insulin in non-β cells.

CUSABIO has long been committed to providing researchers with high-quality proteins, antibodies, ELISA kits and other tools for scientific research reagent products, and has compiled a series of popular targets related to type 1 diabetes research and related reagent products listed below for your selection:

Type 1 Diabetes Mellitus Drug Targets in Development:

Type 1 Diabetes Mellitus Drug Targets Related Products

● Target Proteins

CSB-MP004936HU1 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized CD40L at 2 μg/ml can bind Anti- CD40L Rabbit Monoclonal Antibody(CSB-RA156386A0HU), the EC50 is 2.353-3.232 ng/ml.

CSB-MP004937HU3 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized CD40L at 2 μg/ml can bind Anti- CD40L Rabbit Monoclonal Antibody(CSB-RA156386A0HU), the EC50 is 2.353-3.232 ng/ml.

CSB-MP006163HU1 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized CD152 at 2 μg/ml can bind Anti-CD152 rabbit monoclonal antibody(CSB-RA213310A0HU), the EC50 of human CD152 protein is 27.14-34.82 ng/ml.

CSB-MP009316HU1 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized human GCGR at 2 μg/ml can bind Anti-GCGR recombinant antibody (CSB-RA009316A1HU), the EC50 is 3.747-6.666 ng/mL.

CSB-MP009514HUb1 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized Human GLP1R at 2 μg/mL can bind Anti-GLP1R recombinant antibody (CSB-RA009514MA1HU), the EC50 is 54.54-94.23 ng/mL.

CSB-BP624104HU(M) Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized Human IL17A at 2 μg/ml can bind Anti-IL17A recombinant antibody (CSB-RA624104MA1HU), the EC50 is 1.818-2.170 ng/mL.

CSB-YP011664HU Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized Human IL6 at 2μg/mL can bind Anti-IL6 recombinant antibody (CSB-RA011664MA1HU),the EC50 is 35.80-41.82 ng/mL.

CSB-MP015007HU Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized human CD20 at 2 μg/ml can bind Anti-CD20 recombinant antibody (CSB-RA015007A1HU), the EC50 is 3.243-7.085 ng/mL.

Target Product Name Source Tag Info Product Code
CD2 Recombinant Human T-cell surface antigen CD2 (CD2), partial E.coli N-terminal 6xHis-SUMO-tagged CSB-EP004894HU
CD274 Recombinant Human Programmed cell death 1 ligand 1 (CD274), partial E.coli N-terminal 10xHis-tagged and C-terminal Myc-tagged CSB-EP878942HU2
CD274 Recombinant Human Programmed cell death 1 ligand 1 (CD274), partial (Active) Mammalian cell C-terminal hFc-tagged CSB-MP878942HU1
CD274 Recombinant Dog CD274 molecule (CD274), partial Mammalian cell C-terminal 10xHis-tagged CSB-MP5015DO1
CD274 Recombinant Human Programmed cell death 1 ligand 1 (CD274), partial ( (K136A)) E.coli N-terminal 6xHis-tagged CSB-EP878942HU1(M)
CD28 Recombinant Human T-cell-specific surface glycoprotein CD28 (CD28), partial Mammalian cell C-terminal hFc-tagged CSB-MP004913HU1
CD38 Recombinant Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38), partial Mammalian cell C-terminal hFc-tagged CSB-MP004929HU1
CD38 Recombinant Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38), partial Yeast C-terminal 6xHis-tagged CSB-YP004929HU1
CD38 Recombinant Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38), partial E.coli N-terminal GST-tagged CSB-EP004929HU2
CD40 Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40), partial (Active) Mammalian cell C-terminal Fc-tagged CSB-AP005181HU
CD40 Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40), partial (Active) Mammalian cell C-terminal hFc-tagged CSB-MP004936HU1
CD40 Recombinant Pig Tumor necrosis factor receptor superfamily member 5 (CD40), partial E.coli C-terminal 6xHis-tagged CSB-EP851448PI
CD40 Recombinant Pig Tumor necrosis factor receptor superfamily member 5 (CD40), partial Yeast C-terminal hFc-tagged CSB-YP851448PI
CD40 Recombinant Pig Tumor necrosis factor receptor superfamily member 5 (CD40), partial Yeast C-terminal 6xHis-tagged CSB-YP851448PIc7
CD40 Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40), partial Baculovirus C-terminal hFc-Avi-tagged CSB-BP004936HU1
CD40LG Recombinant Macaca mulatta CD40 ligand (CD40LG), partial E.coli N-terminal 6xHis-tagged CSB-EP004937MOW
CD40LG Recombinant Rabbit CD40 ligand (CD40LG), partial E.coli N-terminal 6xHis-tagged CSB-EP004937RB
CD40LG Recombinant Human CD40 ligand (CD40LG), partial E.coli N-terminal GST-tagged CSB-RP060054h
CD40LG Recombinant Human CD40 ligand (CD40LG), partial Yeast N-terminal 6xHis-tagged CSB-YP004937HU1
CD40LG Recombinant Rabbit CD40 ligand (CD40LG), partial Yeast N-terminal 6xHis-tagged CSB-YP004937RB

● Antibodies

CD40 Recombinant Monoclonal Antibody
CSB-RA004936MA1HU
CSB-RA004936MA1HU FC

Tested Applications:
ELISA, IF, FC

ITGAL Recombinant Monoclonal Antibody
CSB-RA787996A0HU
CSB-RA787996A0HU IF

Tested Applications:
ELISA, WB, IF

PCSK9 Recombinant Monoclonal Antibody
CSB-RA259644A0HU
CSB-RA259644A0HU IHC

Tested Applications:
ELISA, WB, IHC

SELPLG Recombinant Monoclonal Antibody
CSB-RA567010A0HU
CSB-RA567010A0HU IHC

Tested Applications:
ELISA, IHC

- Recombinant Antibody

Target Product Name Species Reactivity Tested Applications Code
CD274 CD274 Recombinant Monoclonal Antibody Human ELISA, WB, IHC CSB-RA977797A0HU
CD274 CD274 Recombinant Monoclonal Antibody Human ELISA, IHC, FC CSB-RA878942MA1HU
CD38 CD38 Recombinant Monoclonal Antibody Human ELISA, WB, IHC CSB-RA796695A0HU
CD40 CD40 Recombinant Monoclonal Antibody Human ELISA, IF, FC CSB-RA004936MA1HU
GCGR GCGR Recombinant Monoclonal Antibody Human ELISA CSB-RA009316A1HU
IL17A IL17A Recombinant Monoclonal Antibody Human ELISA CSB-RA624104MA1HU
IL23A IL23A Recombinant Monoclonal Antibody Human ELISA, WB CSB-RA251959A0HU
IL6 IL6 Recombinant Monoclonal Antibody Human ELISA CSB-RA011664MA1HU
ITGAL ITGAL Recombinant Monoclonal Antibody Human ELISA, WB, IF CSB-RA787996A0HU
MS4A1 CD20 Recombinant Monoclonal Antibody Human ELISA CSB-RA015007A0HU
MS4A1 MS4A1 Recombinant Monoclonal Antibody Human ELISA CSB-RA015007A1HU
MS4A1 MS4A1 Recombinant Monoclonal Antibody Human, Dog, Macaca fascicularis ELISA CSB-RA015007MA3HU
MS4A1 MS4A1 Recombinant Monoclonal Antibody Human ELISA, IHC, IF CSB-RA015007MA4HU
PCSK9 PCSK9 Recombinant Monoclonal Antibody Human ELISA, WB, IHC CSB-RA259644A0HU
SELPLG SELPLG Recombinant Monoclonal Antibody Human ELISA, IHC CSB-RA567010A0HU

- Monoclonal Antibody

Target Product Name Species Reactivity Tested Applications Code
CD2 CD2 Monoclonal Antibody Human,Mouse,Rat ELISA, IHC CSB-MA000227
CD2 CD2 Monoclonal Antibody,FITC Conjugated Human ELISA, IF, FC CSB-MA785710
CD38 CD38 Monoclonal Antibody Human ELISA, IHC CSB-MA785760
IL1B IL1B Monoclonal Antibody Human ELISA CSB-MA065741A0m
IL1B IL1B Monoclonal Antibody Human ELISA, WB, IHC, ICC CSB-MA010884
IL6 IL6 Monoclonal Antibody Human ELISA, WB, IHC CSB-MA067571A0m
ITGAL ITGAL Monoclonal Antibody,FITC Conjugated Human ELISA, IF, FC CSB-MA120024
ITGAL ITGAL Monoclonal Antibody,PE Conjugated Human ELISA, IF, FC CSB-MA897229
MS4A1 MS4A1 Monoclonal Antibody Human,Mouse,Rat ELISA, IHC CSB-MA000204
MS4A1 MS4A1 Monoclonal Antibody Human ELISA, IHC CSB-MA996413
TNF TNF Monoclonal Antibody Bovine ELISA CSB-MA084771A0m
TNF TNF Monoclonal Antibody Human,Mouse,Rat ELISA, WB, IHC CSB-MA080271
TNF TNF Monoclonal Antibody Human,Mouse,Rat ELISA, WB, IHC CSB-MA080272

- Polyclonal Antibody

Target Product Name Species Reactivity Tested Applications Code
CD2 CD2 Antibody Human ELISA, IHC, IF CSB-PA004894LA01HU
CD2 CD2 Antibody Human ELISA, WB CSB-PA005194
CD2 CD2 Antibody Human ELISA, WB CSB-PA004894GA01HU
CD274 CD274 Antibody Human ELISA, IHC CSB-PA878942ESR1HU
CD274 CD274 Antibody Human, Mouse, Rat ELISA, WB, IHC CSB-PA004911GA01HU
CD28 CD28 Antibody Human ELISA, WB CSB-PA005199
CD28 Phospho-CD28 (Y218) Antibody Human, Mouse ELISA, WB CSB-PA070302
CD38 CD38 Antibody Human ELISA, IHC CSB-PA004929ESR1HU
CD38 CD38 Antibody Human ELISA, WB CSB-PA005628
CD38 CD38 Antibody Human ELISA, WB CSB-PA134528
CD38 CD38 Antibody Human ELISA, WB, IHC CSB-PA926996
CD3D CD3D Antibody Human ELISA, IHC CSB-PA004930ESR1HU
CD3D CD3D Antibody Human ELISA, WB CSB-PA001452
CD3D CD3D Antibody Human ELISA, WB CSB-PA005826
CD3D CD3D Antibody Human, Mouse, Rat ELISA, WB, IF CSB-PA004930GA01HU
CD40 CD40 Antibody Human, Mouse ELISA, WB, IF CSB-PA004936LA01HU
CD40 CD40 Antibody Human, Mouse, Monkey ELISA, WB, IHC CSB-PA001455
CD40 Phospho-CD40 (T254) Antibody Human, Mouse ELISA, WB CSB-PA080031
CD40 CD40 Antibody Human ELISA, WB CSB-PA004936GA01HU
CD40 CD40 Antibody Human, Mouse ELISA, IHC CSB-PA215588

● ELISA Kits

CSB-E08054m standard curves

Mouse IL-1β ELISA Kit
CSB-E08054m

265 Citations

CSB-E04638h standard curves

Human IL-6 ELISA KIT
CSB-E04638h

219 Citations

CSB-E04741m standard curves

Mouse TNF-α ELISA KIT
CSB-E04741m

381 Citations

CSB-E04726m standard curves

Mouse TGF-β1 ELISA kit
CSB-E04726m

54 Citations

Target Product Name Sample Types Detection Range Code
CD274 Human Programmed Death Ligand-1(PD-L1/CD274) ELISA Kit serum, plasma, tissue homogenates, cell lysates 15.6 pg/mL-1000 pg/mL CSB-E13644h
CD274 Mouse Programmed cell death 1 ligand 1(CD274) ELISA kit serum, plasma, tissue homogenates 31.25 pg/mL-2000 pg/mL CSB-EL004911MO
CD28 Human soluble cluster of differentiation 28,sCD28 ELISA Kit serum, plasma, tissue homogenates 0.625 ng/mL-40 ng/mL CSB-E09296h
CD38 Human Soluble Cluster of differentiation 38,sCD38 ELISA Kit serum, plasma, tissue homogenates, cell lysates 0.9 ng/mL-60 ng/mL CSB-E09884h
CD38 Mouse ADP-ribosyl cyclase 1(CD38) ELISA kit serum, plasma, tissue homogenates 0.625 ng/mL-40 ng/mL CSB-EL004929MO
CD40 Mouse Tumor necrosis factor receptor superfamily member 5(CD40) ELISA kit Request Information CSB-EL004936MO
CD40LG Human Soluble Cluster of differentiation 40 ligand,sCD40L ELISA Kit serum, plasma, tissue homogenates 0.312 ng/mL-20 ng/mL CSB-E04716h
CD40LG Mouse Soluble Cluster of differentiation 40 ligand,sCD40L ELISA Kit serum, plasma, tissue homogenates, cell culture supernates. 0.274 ng/ml-200 ng/ml. CSB-E04717m
CD40LG Rat Soluble Cluster of differentiation 40 ligand,sCD40L ELISA Kit serum, plasma, tissue homogenates 1.87 ng/mL-120 ng/mL CSB-E07395r
IL12A Bovine Interleukin 12,IL-12 ELISA Kit serum, plasma, tissue homogenates 6.25 pg/mL-400 pg/mL CSB-E14010B
IL17A Mouse Interleukin 17,IL-17 ELISA Kit serum, plasma, tissue homogenates, cell culture supernates 10.938 pg/ml-700 pg/ml CSB-E04608m-IS
IL17A Mouse Interleukin 17,IL-17 ELISA Kit serum, plasma, tissue homogenates 78 pg/ml - 5000 pg/ml CSB-E04608m
IL17A Rat Interleukin 17,IL-17 ELISA KIT serum, plasma, tissue homogenates 93.75 pg/mL-6000 pg/mL CSB-E07451r
IL17A Pig interleukin 17,IL-17 ELISA Kit serum, plasma, tissue homogenates 20 pg/mL- 800 pg/mL CSB-E08057p
IL17A Human Interleukin 17A (IL-17A/IL-17) ELISA Kit serum, plasma, tissue homogenates 62.5 pg/ml - 4000 pg/ml CSB-E12819h
IL1B Human Interleukin 1β,IL-1β ELISA Kit serum, plasma, tissue homogenates, cell culture supernates 2.344 pg/ml-150 pg/ml CSB-E08053h-IS
IL1B Mouse Interleukin 1β,IL-1β ELISA Kit serum, plasma, tissue homogenates, cell culture supernates 12.5 pg/ml-800 pg/ml CSB-E08054m-IS
IL1B Pig Interleukin 1β,IL-1β ELISA Kit serum, plasma, cell culture supernates, tissue homogenates 3.9 pg/mL-250 pg/mL CSB-E06782p
IL1B Rabbit Interleukin 1β,IL-1β ELISA Kit serum, plasma, tissue homogenates 7.8 pg/mL-500 pg/mL CSB-E06900Rb
IL1B Human Interleukin 1β,IL-1β ELISA Kit serum, plasma, tissue homogenates 7.8 pg/ml - 500 pg/ml CSB-E08053h



Reference:

[1] Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment. Diabetes Care, 2014.

[2] CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes. Expert Opin Investig Drugs, 2020.

[3] GLP-1 as a target for therapeutic intervention. Curr Opin Pharmacol, 2016.

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1